Mostafa Heidari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mostafa Heidari has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Abbas Masjedi-Arani
Department of Clinical Psychology, School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran
1 shared publication Ahmad Masoumi
Eye Research Center, Farabi Eye Hospital, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publicationAhmad Yousefi
School of medicine), Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication- Alireza Mashaghi
Medical Systems Biophysics and Bioengineering, Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
1 shared publication Amirhossein Aghajani
Department of Plastic and Reconstructive Surgery, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication- Farsad Noorizadeh
Basir Eye Health Research Center, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 24 June 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Superficial ocular vascular changes after orbital decompression in patients with thyroid ophthalmopathy measured by anterior segment OCT angiography; an observational study
Thyroid eye disease (TED) is a common ophthalmologic manifestation of thyroid dysfunction. Despite various imaging techniques available, there hasn't been a widely adopted method for assessing the anterior segment vasculature in TED patients. Our study aimed to evaluate alterations in ocular surface circulation following orbital decompression surgery in TED patients and investigate factors influencing these changes. Using anterior segment optical coherence tomography-angiography (AS-OCTA), we measured ocular surface vascularity features, including vessel density (VD), vessel diameter index (VDI), and vessel length density (VLD), both before and after decompression surgery, alongside standard ophthalmic examinations. Our AS-OCTA analysis revealed a significant decrease in most of the temporal vasculature measurements six weeks post-surgery (p < 0.05). However, differences in the nasal region were not statistically significant. These findings indicate notable changes in ocular surface circulation following orbital decompression in TED patients, which may have implications for intraocular pressure (IOP) control and ocular surface symptoms management. AS-OCTA holds promise as a tool for evaluating the effectiveness of decompression surgery and assessing the need for further interventions.
- 24 June 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Open AccessSuperficial ocular vascular changes after orbital decompression in patients with thyroid ophthalmopathy measured by anterior segment OCT angiography; an observational study
Thyroid eye disease (TED) is a common ophthalmologic manifestation of thyroid dysfunction. Despite various imaging techniques available, there hasn't been a widely adopted method for assessing the anterior segment vasculature in TED patients. Our study aimed to evaluate alterations in ocular surface circulation following orbital decompression surgery in TED patients and investigate factors influencing these changes. Using anterior segment optical coherence tomography-angiography (AS-OCTA), we measured ocular surface vascularity features, including vessel density (VD), vessel diameter index (VDI), and vessel length density (VLD), both before and after decompression surgery, alongside standard ophthalmic examinations. Our AS-OCTA analysis revealed a significant decrease in most of the temporal vasculature measurements six weeks post-surgery (p < 0.05). However, differences in the nasal region were not statistically significant. These findings indicate notable changes in ocular surface circulation following orbital decompression in TED patients, which may have implications for intraocular pressure (IOP) control and ocular surface symptoms management. AS-OCTA holds promise as a tool for evaluating the effectiveness of decompression surgery and assessing the need for further interventions.
- Open Access
- 16 February 2022
- Published by Discovery Scientific Society in Medical Science
- Vol. 26 (120) , 1
Factors related to compliance with official guidelines of covid-19 measures among Iranian population: The predictive role of social alienation, trust and morality
- 16 February 2022
- Published by Discovery Scientific Society in Medical Science
- Vol. 26 (120) , 1
Open AccessFactors related to compliance with official guidelines of covid-19 measures among Iranian population: The predictive role of social alienation, trust and morality
- Open Access
- 11 September 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (9) , 1439
Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy
Dry eye disease (DED) is among the most common ocular disorders affecting tens of millions of individuals worldwide; however, the condition remains incompletely understood and treated. Valuable insights have emerged from multidisciplinary approaches, including immunometabolic analyses, microbiome analyses, and bioengineering. Furthermore, we have seen new developments in clinical assessment approaches and treatment strategies in the recent past. Here, we review the emerging frontiers in the pathobiology and clinical management of DED.
- 11 September 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (9) , 1439
Open AccessDry Eye Disease: Emerging Approaches to Disease Analysis and Therapy
Dry eye disease (DED) is among the most common ocular disorders affecting tens of millions of individuals worldwide; however, the condition remains incompletely understood and treated. Valuable insights have emerged from multidisciplinary approaches, including immunometabolic analyses, microbiome analyses, and bioengineering. Furthermore, we have seen new developments in clinical assessment approaches and treatment strategies in the recent past. Here, we review the emerging frontiers in the pathobiology and clinical management of DED.